Literature DB >> 21336601

Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.

Yonggang Wei1, Fei Liu, Bo Li, Xi Chen, Yu Ma, Lvnan Yan, Tianfu Wen, Mingqing Xu, Wentao Wang, Jiayin Yang.   

Abstract

BACKGROUND: Studies investigating the associations between tumor necrosis factor-alpha (TNFA) polymorphisms and hepatocellular carcinoma (HCC) risk report conflicting results. We conducted a meta-analysis to assess the association between TNFA gene TNFA-308(G/A), TNFA-238(G/A), TNFA-863(C/A), TNFA-857(C/T), TNFA-1031 (T/C) polymorphisms and HCC susceptibility.
METHODS: Two investigators independently searched the Medline, Embase, CNKI, and Chinese Biomedicine Database. Summary odds ratios (ORs) and 95% confidence intervals (95% CIs) for TNFA polymorphisms and HCC were calculated in a fixed-effects model (the Mantel-Haenszel method) and a random-effects model (the DerSimonian and Laird method) when appropriate.
RESULTS: This meta-analysis included 17 case-control studies, which included 2,357 HCC cases and 3,161 controls. Overall, the variant genotypes AA/AG of -308G/A were associated with a significantly increased HCC risk, when compared with GG genotype (AA vs. GG, OR=1.97, 95%CI=1.01-3.83; AG vs. GG, OR=1.88, 95%CI=1.23-2.88; AA/AG vs. GG, OR=1.80, 95%CI=1.19-2.72). When stratifying for ethnicity, significantly elevated HCC risk was found among Asians. Moreover, similar results were observed between TNFA-238G/A, TNFA-863C/A polymorphisms and HCC risk among Asians (for -238G/A, AG vs. GG OR=1.63, 95%CI=1.17-2.26, AA/AG vs. GG OR=1.61, 95%CI=1.16-2.24; for -863 C/A, AC vs. CC OR=1.72, 95%CI=1.03-2.88, AA/AC vs. CC OR=1.71, 95%CI=1.02-2.86), while no associations were observed between TNFA-857C/T, TNFA-1031T/C polymorphisms and HCC susceptibility.
CONCLUSIONS: This meta-analysis shows that TNFA-308G/A, TNFA-238G/A and TNFA-863C/A polymorphisms may be associated with HCC among Asians. TNFA-857C/T and TNFA-1031T/C polymorphisms were not detected to be related to the risk for HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336601     DOI: 10.1007/s10620-011-1617-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  58 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection.

Authors:  Grazia Anna Niro; Rosanna Fontana; Domenica Gioffreda; Maria Rosa Valvano; Angelo Lacobellis; Domenico Facciorusso; Angelo Andriulli
Journal:  Liver Int       Date:  2005-12       Impact factor: 5.828

Review 3.  Risk of HCC: genetic heterogeneity and complex genetics.

Authors:  Tommaso A Dragani
Journal:  J Hepatol       Date:  2009-11-24       Impact factor: 25.083

4.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

5.  Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.

Authors:  H Kuper; A Tzonou; E Kaklamani; C C Hsieh; P Lagiou; H O Adami; D Trichopoulos; S O Stuver
Journal:  Int J Cancer       Date:  2000-02-15       Impact factor: 7.396

6.  Influence of TNFalpha gene polymorphisms on TNFalpha production and disease.

Authors:  A H Hajeer; I V Hutchinson
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

Review 7.  Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer.

Authors:  G Mark Anderson; Marian T Nakada; Mark DeWitte
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

Review 8.  Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.

Authors:  Francesco Feo; Maddalena Frau; Maria L Tomasi; Stefania Brozzetti; Rosa M Pascale
Journal:  Exp Biol Med (Maywood)       Date:  2009-05-08

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.

Authors:  Jen-Eing Jeng; Huey-Ru Tsai; Lee-Yea Chuang; Jung-Fa Tsai; Zu-Yau Lin; Min-Yuh Hsieh; Shin-Chern Chen; Wan-Lung Chuang; Liang-Yen Wang; Ming-Lung Yu; Chia-Yen Dai; Jan-Gowth Chang
Journal:  Medicine (Baltimore)       Date:  2009-11       Impact factor: 1.889

View more
  24 in total

Review 1.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

2.  Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.

Authors:  Chun Wang; Jianping Gong; Hao Wu
Journal:  Biomed Rep       Date:  2017-06-14

3.  Human genetic variation and the risk of hepatocellular carcinoma development.

Authors:  Sayeh Ezzikouri; Soumaya Benjelloun; Pascal Pineau
Journal:  Hepatol Int       Date:  2013-08-02       Impact factor: 6.047

Review 4.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

5.  Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.

Authors:  Esra Çil; Alkın Kumral; Müge Kanmaz-Özer; Pervin Vural; Semra Doğru-Abbasoğlu; Yüksel Altuntaş; Müjdat Uysal
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

6.  Molecular Epidemiology of Hepatocellular Carcinoma.

Authors:  Yujin Hoshida
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-12-01

7.  Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Dawei Chen; Shuanghai Liu; Sheng Chen; Zhaowen Wang; Zehua Wu; Kai Ma; Junwei Fan; Zhihai Peng
Journal:  Int J Clin Oncol       Date:  2016-07-01       Impact factor: 3.402

8.  Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.

Authors:  Suk Pyo Shin; Nam Keun Kim; Ju Hwan Kim; Ju Ho Lee; Jung Oh Kim; Sung Hwan Cho; Hana Park; Mi Na Kim; Kyu Sung Rim; Seong Gyu Hwang
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

9.  Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Jian-Hong Zhong; Xue-Mei You; Wen-Feng Gong; Liang Ma; Yu Zhang; Qin-Guo Mo; Liu-Cheng Wu; Jun Xiao; Le-Qun Li
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection.

Authors:  Sirous Tayebi; Ashraf Mohamadkhani
Journal:  Hepat Res Treat       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.